Harbour BioMed (HKEX: 02142) announced today it has entered into a multi-year, multifaceted research collaboration agreement with Dana-Farber Cancer Institute to co-develop novel biotherapies in cancer treatment. Harbour BioMed scientists and Dana-Farber researchers will be ...
Sir Richard will use his extensive experience in biotechnology and pharmaceuticals to lead the significant programme of work to find, procure and deliver vaccines to support the largest vaccination programme in British history. He has ...
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Paul Burton, M.D., Ph.D., F.A.C.C, M.R.C.S will join the Company as Chief Medical Officer, effective July 6, 2021. He will ...
Popular Posts
